跳至主要内容
临床试验/DRKS00017294
DRKS00017294已完成不适用

PROSPECTIVE OBSERVATIONAL STUDY ON THE UTILISATION AND TREATMENT RESULTS OF PATIENTS NEWLY TREATED WITH DROPIZOL® (OPIUM TINCTURE) UNDER CONDITIONS OF EVERYDAY PRACTICE - CLARIFY DROPIZOL®

GWT-TUD GmbH, Medizin0 个研究点目标入组 62 人开始时间: 2019年5月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Severe diarrhoea, e.g. diarrhoea caused by cytostatic drugs, radiation or neuroendocrine tumours, if the application of other antidiarrheal drugs has not produced a sufficient effect.
  • Written consent before the first documentation.
  • Newly treated with Dropizol® within the provisions of the Summary of Product Characteristics (SPC)

排除标准

  • Contraindications as described in the Summary of Product Characteristics
  • Lack of cognitive and linguistic ability to participate in the study
  • Patient (probably) not available for follow-up period (up to 6 months)
  • Pregnancy

研究者

发起方
GWT-TUD GmbH, Medizin

相似试验